Insmed (INSM) PT Raised to $108 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $109.31 -2.9%
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
RBC Capital analyst Leonid Timashev raised the price target on Insmed (NASDAQ: INSM) to $108.00 (from $106.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $201 at Guggenheim
- SEPLAT Petro (SEPL:LN) PT Raised to GBP9.60 at Canaccord
- UPL Ltd. (UPLL:IN) PT Raised to INR580 at Kotak
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
